GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,361.50p
   
  • Change Today:
      15.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,300.00
  • Currency: UK Pounds
  • Shares Issued: 4,145.13m
  • Volume: 4,493,335
  • Market Cap: £56,436m
  • RiskGrade: 129

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
16-Apr-24 Buy Dividends Hal Barron 3,202.70p 2,906,213 £93,077,316.08
16-Apr-24 Buy Dividends Emma Walmsley 1,611.28p 1,840,922 £29,662,409.10
16-Feb-24 Sell Emma Walmsley 1,657.97p 139,792 £2,317,709.49
01-Feb-24 Buy Julie Brown 1,582.80p 19,360 £306,430.08
16-Aug-24 Buy Dividends Hal Barron 4,128.00p 2,735 £112,907.49
22-Feb-24 Buy Hal Barron 1,737.62p 5,547 £96,385.75
30-Oct-24 Buy Jonathan Symonds 1,393.65p 7,150 £99,645.97
15-Nov-24 Buy Hal Barron 2,643.57p 3,447 £91,126.43
16-Jul-24 Buy Hal Barron 2,985.56p 2,859 £85,363.23
16-May-24 Buy Dividends Hal Barron 3,542.25p 2,433 £86,183.04
16-Jan-24 Buy Dividends Hal Barron 2,002.20p 3,947 £79,026.83
15-Jan-24 Buy Dividends Emma Walmsley 1,556.40p 4,947 £76,999.84
23-Sep-24 Buy Charles Bancroft 1,536.13p 3,602 £55,331.55
20-Dec-24 Buy Charles Bancroft 1,345.06p 4,368 £58,752.23
20-Jun-24 Buy Charles Bancroft 3,220.87p 1,811 £58,329.90
20-Mar-24 Buy Charles Bancroft 1,638.72p 3,306 £54,176.05
01-Feb-24 Buy Jonathan Symonds 1,570.62p 3,500 £54,971.70
15-Oct-24 Buy Dividends Emma Walmsley 1,505.00p 3,618 £54,450.90
20-Mar-24 Buy Jonathan Symonds 1,659.89p 2,900 £48,136.81
20-Jun-24 Buy Vishal Sikka 3,220.87p 1,179 £37,974.02

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,361.50p
Change Today 15.00p
% Change 1.11 %
52 Week High 1,812.50
52 Week Low 1,300.00
Volume 4,493,335
Shares Issued 4,145.13m
Market Cap £56,436m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.14% below the market average0.14% below the market average0.14% below the market average0.14% below the market average0.14% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Price Trend
25.09% below the market average25.09% below the market average25.09% below the market average25.09% below the market average25.09% below the market average
38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average
Income
37.50% above the market average37.50% above the market average37.50% above the market average37.50% above the market average37.50% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
2.97% below the market average2.97% below the market average2.97% below the market average2.97% below the market average2.97% below the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 14
Sell 2
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-24 15-Aug-24
Paid 09-Jan-25 10-Oct-24
Amount 15.00p 15.00p

Trades for 02-Jan-2025

Time Volume / Share Price
15:43 296 @ 1,362.00p
15:38 0 @ 1,361.00p
15:36 0 @ 1,361.50p
15:34 0 @ 1,362.00p
15:25 0 @ 1,362.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page